Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/28/2025

First-Line Antibiotic Treatment for Pneumonia

Treatment Recommendations

  • The American Thoracic Society recommends amoxicillin as the first-line antibiotic treatment for community-acquired pneumonia in most patients, particularly for outpatient management 1, 2, 3
  • For healthy adults without comorbidities, the American College of Chest Physicians recommends amoxicillin 1g three times daily as the first choice, or doxycycline 100mg twice daily as an alternative 1
  • For adults with comorbidities, the American College of Chest Physicians recommends combination therapy with amoxicillin/clavulanate or cephalosporin plus a macrolide or doxycycline 1, 4

Hospitalized Patients

  • The British Thoracic Society recommends combined oral therapy with amoxicillin and a macrolide for hospitalized patients with non-severe community-acquired pneumonia 2, 3
  • For severe community-acquired pneumonia requiring hospitalization, the European Respiratory Society recommends immediate parenteral antibiotics with a broad-spectrum β-lactamase stable antibiotic plus a macrolide 2, 3, 5

Special Considerations

  • The Infectious Diseases Society of America recommends a duration of therapy of 7 days for most uncomplicated pneumonia, 10 days for severe microbiologically undefined pneumonia, and 14-21 days for legionella, staphylococcal, or gram-negative enteric bacilli pneumonia 2, 4, 5
  • The American Thoracic Society recommends considering treatment failure if patients on amoxicillin monotherapy do not improve, and adding or substituting a macrolide 1, 2